A study led by Dr. Stephen J. Kent found that components of the Moderna SPIKEVAX COVID-19 vaccine, including mRNA and lipid nanoparticles, can persist in the bloodstream for up to 28 days after injection. The research tracked 19 participants and detected vaccine components as early as four hours after administration, with peak levels at one to two days. The study suggests that the persistence of these components might be linked to an increased antibody response against polyethylene glycol (PEG), a vaccine delivery system component. Critics argue that such findings should have been disclosed before vaccine approval and emphasize the need for further investigation into the long-term implications of these components in the body.
Editor’s Note: It’s troubling that such critical data were not disclosed to the FDA before vaccine approval, as highlighted by critics like Dr. Michael Palmer. This lack of disclosure undermines trust in the regulatory process. Moderna has a history of undisclosed side effects of their vaccine, and this is one more thing to add to the roster. [See also: The truth is coming out: mRNA shots cause blood clots, Moderna Scientists Raise Concerns About Toxicity Risks of mRNA Tech Used in Their COVID Vaccines]
Read Original Article
Read Online
Click the button below if you wish to read the article on the website where it was originally published.
Read Offline
Click the button below if you wish to read the article offline.